Alon Lazarus serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Alon Lazarus has executed 7 insider transactions totaling $8.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 4, 2021 involved exercising options for 1,235,917 shares valued at $0.
Alon Lazarus currently holds 1,235,917 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alon Lazarus has been a net buyer of KROS stock. They have purchased $8.3M and sold $0 worth of shares.
Alon Lazarus's most recent insider trade was on May 4, 2021, when they sold 1,235,917 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 4, 2021 | HOWL | $6.4M | Purchase | 400,000 | $16.00 | Discretionary |
| Apr 13, 2020 | KROS | $1.9M | Purchase | 120,000 | $16.00 | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 167,537 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 343,270 | $N/A | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 1,382,295 | $N/A | Discretionary |